A highly selective, cell-permeable furin inhibitor BOS-318 rescues key features of cystic fibrosis airway disease (2022)
Attributed to:
Queen’s P2D 2017: Building on Successful Foundations and Developing New Approaches
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.chembiol.2022.02.001
Publication URI: http://dx.doi.org/10.1016/j.chembiol.2022.02.001
Type: Journal Article/Review
Parent Publication: Cell Chemical Biology
Issue: 6
ISSN: 2451-9456